http://www.bluebirdbio.com
bluebird bio, Inc. Company Intro
Headquartered in Cambridge, MA, bluebird bio develops pioneering gene therapies for severe genetic diseases and cancers. Learn more at bluebirdbio.com.
Industry
Healthcare
bluebird bio, Inc. Headquaters
60 Binney Street
Cambridge,02142
United States
bluebird bio, Inc. Share price
19 Jan 2021 01:14 GMT
$51.80
-0.05 (-0.1 %)
bluebird bio, Inc. Market cap
$3.354 B
WMC RANKING
2021
bluebird bio, Inc. # 33
BiotechnologyLatest bluebird bio, Inc. News
18 Jan 2021
CAR T Cell Therapy Market 2018 Professional Survey Report; Industry Growth, Shares, Opportunities And Forecast To 2026 | Novartis International AG, Kite Pharma, Inc. (Gilead Sciences, Inc.)
... Inc.), Juno Therapeutics (Celgene Corporation), Bluebird Bio, Inc. (Celgene ... Inc., Aurora Biopharma Inc., Legend Biotech (Genscript Biotech Corporation), ...
18 Jan 2021
Personalized Cell Therapy Market Shows Expected Growth from 2018-2026 | Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc.
... Inc., Saneron CCEL Therapeutics, Inc., MolMed S.p.A., Vericel Corporation, Novartis AG, Gilead Sciences, Inc., Celgene Corporation, Bluebird Bio, Inc. and ...
18 Jan 2021
Gene Therapy for Rare Disease Market Revenue Growth Predicted by 2018-2026 | Kite Pharma, Inc. (Gilead Sciences, Inc.), Novartis International AG
(Celgene Corporation), Bluebird Bio, Inc., Spark Therapeutics, Inc., uniQure N.V, Orchard Therapeutics Plc., PTC Therapeutics, Inc., and BioMarin Pharmaceutical ...
WMC Market Score
WMC Market to Revenue Score
bluebird bio, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| bluebird bio, Inc. | USD | $250,023 | $898,807 | $-642,168 | $33,540B | 33 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,660B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,740B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $586,520B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $273,380B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total bluebird bio, Inc. Social Followers vs Top 4 Industry Competitors
bluebird bio, Inc. Post vs Top 4 Industry Competitors
bluebird bio, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
bluebird bio, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
bluebird bio, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| bluebird bio, Inc. | 2.70 | 15.53 | 100 | 0 | 0 | 0 | 60.29 |
| Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 18.92 | 100 | 0 | 0 | 96.49 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 65.88 | 60 | 0 | 0 | 74.14 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 5.80 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
